Docetaxel and Irinotecan in Treating Patients With Advanced Solid Tumors

NCT00004923 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: docetaxel
DRUG: irinotecan hydrochloride

Sponsor

Yale University

Collaborators

[object Object]